tiprankstipranks
Trending News
More News >
Red Light Holland (TSE:TRIP)
:TRIP

Red Light Holland (TRIP) AI Stock Analysis

Compare
59 Followers

Top Page

TS

Red Light Holland

(OTC:TRIP)

51Neutral
Red Light Holland's stock score is weighed down by significant challenges in profitability and cash flow. Despite this, a strong equity position and positive corporate events provide some hope for future growth. Technical analysis indicates a neutral trend, and valuation remains unattractive due to negative earnings.

Red Light Holland (TRIP) vs. S&P 500 (SPY)

Red Light Holland Business Overview & Revenue Model

Company DescriptionRed Light Holland Corp. engages in the production, cultivation, and sale of magic truffles to the recreational market in the Netherlands. It is also involved in the selection, distribution, and export of truffles, cannabidiol products, cannabis seeds, headshop products, cannabis bake house muffins, cookies, and cakes. The company sells its products under the iMicrodose and Maka brand name through 74 brick-and-mortar SmartShops, as well as through iMicrodose.nl and various other online stores across the Netherlands. Red Light Holland Corp. is based in Toronto, Ontario.
How the Company Makes MoneyRed Light Holland generates revenue primarily through the cultivation and sale of magic truffles, which are distributed across various retail and online channels. The company focuses on both direct-to-consumer sales and partnerships with established distributors in regions where psychedelic substances are legally permissible. Revenue is also derived from strategic collaborations and joint ventures that enhance its market reach and product development. Additionally, Red Light Holland invests in education and advocacy efforts to support the safe and informed use of its products, which indirectly contributes to its commercial success.

Red Light Holland Financial Statement Overview

Summary
Red Light Holland shows revenue growth but struggles with profitability and cash flow. The strong equity position provides stability, yet persistent net losses and negative cash flows indicate a need for strategic improvements in operational efficiency and profitability.
Income Statement
45
Neutral
Red Light Holland shows a positive revenue growth trajectory, increasing from 2020 to 2024. However, the company struggles with negative net profit margins and EBIT, indicating profitability challenges. The TTM data highlights a gross profit margin of 31.22%, but the net income remains negative, reflecting ongoing operational inefficiencies.
Balance Sheet
55
Neutral
The company maintains a strong equity position with an equity ratio of 83.15% in the TTM period, reflecting financial stability. However, the debt-to-equity ratio is low at 0.10, showing limited leverage but a need for more efficient capital utilization. Return on equity is negative due to consistent net losses, indicating underperformance in generating returns on shareholder investments.
Cash Flow
40
Negative
Free cash flow remains negative, though showing some improvement over the years. The operating cash flow to net income ratio is negative, highlighting challenges in converting income into cash. Despite the pharmaceutical industry’s capital demands, the cash flow situation signals a need for better cash management and operational efficiency.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
2.52M4.75M3.95M2.33M110.96K0.00
Gross Profit
811.13K2.02M1.71M617.68K19.35K0.00
EBIT
-7.43M-6.19M-4.95M-9.51M-4.65M-325.17K
EBITDA
-6.63M-5.26M-4.32M-8.55M-4.61M0.00
Net Income Common Stockholders
-12.41M-7.63M-5.40M-14.37M-1.64M-325.17K
Balance SheetCash, Cash Equivalents and Short-Term Investments
14.37M14.17M18.53M26.62M32.78M1.96M
Total Assets
24.08M24.08M30.14M32.94M36.30M3.97M
Total Debt
811.05K1.72M1.77M1.50M866.50K86.77K
Net Debt
-13.56M-12.46M-16.72M-24.59M-30.32M-1.88M
Total Liabilities
3.82M3.82M3.80M3.78M2.24M5.11M
Stockholders Equity
20.07M20.07M26.06M28.48M34.06M-1.14M
Cash FlowFree Cash Flow
-7.73M-3.92M-6.45M-5.28M-3.63M-238.35K
Operating Cash Flow
-4.79M-3.23M-4.39M-4.88M-3.36M-238.35K
Investing Cash Flow
-2.57M-650.43K-3.17M-582.74K-201.55K-1.80M
Financing Cash Flow
341.15K-206.95K-114.16K451.76K32.78M4.01M

Red Light Holland Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.03
Negative
100DMA
0.04
Negative
200DMA
0.04
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
39.64
Neutral
STOCH
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:TRIP, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.03, below the 50-day MA of 0.03, and below the 200-day MA of 0.04, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 39.64 is Neutral, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:TRIP.

Red Light Holland Peers Comparison

Overall Rating
UnderperformOutperform
Sector (52)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
52
Neutral
$5.15B3.56-42.52%2.83%14.56%-0.50%
51
Neutral
$10.02M-30.44%13.57%-14.29%
TSRVV
46
Neutral
C$12.56M-66.49%-4.84%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:TRIP
Red Light Holland
0.03
-0.03
-54.55%
TSE:NUMI
Numinus Wellness
0.04
-0.04
-50.00%
TSE:RVV
Revive Therapeutics
0.03
0.00
0.00%
CYBN
Cybin
7.05
-6.02
-46.06%
HAVLF
HAVN Life Sciences
0.01
0.00
0.00%

Red Light Holland Corporate Events

Product-Related AnnouncementsBusiness Operations and Strategy
Happy Caps Mushroom Kits Debut in U.S. Safeway Stores
Positive
Apr 22, 2025

Red Light Holland’s subsidiary, Happy Caps Mushroom Farm, has launched its mushroom home grow kits in 66 Safeway stores across Oregon and Washington, marking its first U.S. retail rollout. This expansion introduces popular mushroom varieties to a region known for its appreciation of fresh, organic, and sustainable food, and signifies a strategic partnership with Albertsons, which operates over 2,200 stores nationwide. The collaboration with Trailbridge Farms ensures local production and quality assurance, reflecting a growing consumer interest in functional mushrooms and positioning Happy Caps for further market expansion.

Spark’s Take on TSE:TRIP Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRIP is a Neutral.

Red Light Holland’s stock faces significant challenges in profitability and technical indicators, impacting its overall score. However, positive corporate events and strategic partnerships provide hope for future growth. The company’s financial stability is underpinned by a strong equity position, though persistent operational inefficiencies and negative cash flows remain key concerns.

To see Spark’s full report on TSE:TRIP stock, click here.

Product-Related AnnouncementsBusiness Operations and StrategyRegulatory Filings and Compliance
Red Light Holland and Irvine Labs Achieve Key Milestone with 2025 Psilocybin DEA Quotas
Positive
Apr 15, 2025

Red Light Holland has announced a significant milestone in its partnership with Irvine Labs, as the latter has received its 2025 psilocybin DEA quotas, including an import quota. This development allows Red Light Holland to proceed with the import permit application process to ship its naturally derived psilocybin from its Netherlands farm to Irvine Labs in California. The collaboration aims to leverage Irvine Labs’ expertise in manufacturing and compliance to enhance the stability and shelf life of Red Light Holland’s microdosing capsules, positioning the company to expand into global emerging legal markets. The partnership focuses on developing a commercialized product for export to emerging markets and use in government-funded pilot programs and clinical trials in the United States.

Spark’s Take on TSE:TRIP Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRIP is a Neutral.

Red Light Holland’s stock faces significant challenges in profitability and technical indicators, impacting its overall score. However, positive corporate events and strategic partnerships provide hope for future growth. The company’s financial stability is underpinned by a strong equity position, though persistent operational inefficiencies and negative cash flows remain key concerns.

To see Spark’s full report on TSE:TRIP stock, click here.

Product-Related AnnouncementsBusiness Operations and Strategy
Red Light Holland’s Happy Caps Expands into U.S. Market with Safeway Partnership
Positive
Apr 7, 2025

Red Light Holland’s subsidiary, Happy Caps Mushroom Farm, has secured a purchase order with Albertsons Companies for its first U.S. retail launch through Safeway stores in Oregon. This strategic partnership will introduce three varieties of Happy Caps Mushroom Home Grow Kits to 66 Safeway locations, marking a significant expansion into the U.S. market. The collaboration with Trailbridge Farms in Oregon ensures product freshness and improved margins, highlighting the growing demand for innovative mushroom products in the health and wellness sector.

Spark’s Take on TSE:TRIP Stock

According to Spark, TipRanks’ AI Analyst, TSE:TRIP is a Neutral.

Red Light Holland faces major challenges in profitability and cash flow, significantly impacting its financial health. The stock’s current technical indicators suggest bearish momentum, and its valuation is not appealing due to negative earnings. However, recent corporate events, including strategic partnerships and leadership enhancements, offer a glimmer of hope for future growth and operational improvement.

To see Spark’s full report on TSE:TRIP stock, click here.

Executive/Board ChangesBusiness Operations and Strategy
Red Light Holland Strengthens Board with New Appointment
Positive
Mar 19, 2025

Red Light Holland has appointed Michael Galloro to its Board of Directors, enhancing its leadership with his extensive experience in public markets, strategic transactions, and corporate governance. Galloro’s proven success in scaling consumer brands is expected to drive sustainable growth and enhance shareholder value as the company expands its functional mushroom and psilocybin truffle offerings.

Product-Related AnnouncementsBusiness Operations and Strategy
Red Light Holland Expands Partnership with Costco Canada for Mushroom Home Grow Kits
Positive
Mar 13, 2025

Red Light Holland, through its subsidiary Happy Caps Mushroom Farms, has received an Informal Projection Letter from Costco Canada for 20,160 units of its ‘Mega Block’ 2kg Mushroom Home Grow Kits. This development, scheduled for delivery in May 2025, signifies a strengthened partnership with Costco Canada and highlights the growing demand for sustainable home grow kits. The company is also eyeing further expansion in North America, including potential orders with a major U.S. retailer.

Business Operations and StrategyFinancial Disclosures
Red Light Holland Reports Q3 2025 Results, Highlights Strategic Growth
Positive
Feb 26, 2025

Red Light Holland reported its financial results for the third quarter of 2025, highlighting a cash balance of $13.3 million and a revenue of $1.2 million for the quarter. Despite a slight decline in quarterly revenue due to lower wholesale mushroom sales and a returned purchase order from Costco Canada, the company achieved a year-over-year revenue increase of 5.1%. The company also reduced its EBITDA loss, reflecting its commitment to sustainable growth and strategic partnerships. Red Light Holland’s diversified portfolio and upcoming partnerships, including a re-order with Costco Canada and a new purchase order with a major U.S. retailer, position it for continued success in the emerging legal psilocybin market.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.